Serum Sickness-Like Reaction Associated with Epstein – Barr Virus: Clinical Case

Background. Annular dermatoses are a group of diseases with major clinical manifestation of rashes of relevant form. This manifestation pattern causes difficulties in diagnosis. The case of rarely diagnosed annular dermatosis is presented: serum siknesslike reaction (SSLR) triggered by the Epstein – Barr virus (EBV).

Clinical case description. Patient D., 8 years old girl, noted abdominal pain 3 weeks before hospitalization, and later numerous polymorphic rashes (erythematous macules, urticarial elements), swelling and pain in joints. Self-treatment with non-steroidal anti-inflammatory and systemic antihistamines did not lead to any improvement. The patient was hospitalized in the pediatric department at the place of residence, where the diagnosis “Henoch-Schonlein purpura, mixed type” was established according to the results of physical, laboratory (double increase of ALT and AST, ESR up to 166 mm/h, IgM to EBV), and ultrasound (mesenteric lymph nodes hyperplasia) studies. Systemic glucocorticosteroids have led to improvement, however, few days after the end of the treatment there was relapse of rash and arthralgia. Thus, the girl was administrated to clinical diagnostic center. Patient’s general condition was satisfactory at the time of examination. There were numerous erythematous annular urticarial and macular elements (3–12 cm) on the skin of face, body and limbs. Some foci, as well as some resolved rashes had blue spots with indistinct boundaries that disappeared after compression. Mucous membranes, nails and hair were intact. Subjective symptoms — slight burning around rashes, at palpation — low-intensity pain in the left radiocarpal joint. Blood tests: C-reactive protein concentration increased up to 12 mg/L, ESR up to 26 mm/h, IgG to EBV up to 47.7.

Conclusion. During differential diagnosis we should consider the possibility of SSLR development in all pediatric patients with annular rashes associated with arthralgia and/or arthritis, fever, history of drug use (most often beta-lactam antibiotics), recent vaccination or manifestations of viral infection, especially in case of cyanotic spots after rashes resolution and non-specific laboratory parameters.

1. Todd PS, Orlowski T, Schumacher-Kim W. A Review of Annular Eruptions in Children. Pediatr Ann. 2015;44(8):e199–e204. doi: https://doi.org/10.3928/00904481-20150812-09

2. Delli Colli L, Gabrielli S, Abrams EM, et al. Differentiating Between β-Lactam-Induced Serum Sickness-Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge. J Allergy Clin Immunol Pract. 2021;9(2):916–921. doi: https://doi.org/10.1016/j.jaip.2020.08.047

3. Del Pozzo-Magaña BR, Abuzgaia A, Murray B, et al. Paediatric serum sickness-like reaction: A 10-year retrospective cohort study. Paediatr Child Health. 2021;26(7):428–435. doi: https://doi.org/10.1093/pch/pxab003

4. Chiong FJ, Loewenthal M, Boyle M, Attia J. Serum sickness-like reaction after influenza vaccination. BMJ Case Rep. 2015;2015: bcr2015211917. doi: https://doi.org/10.1136/bcr-2015-211917

5. Gupta R, Fakunle I, Samji V, Hale EB. Serum Sickness-Like Reaction Associated With Acute Hepatitis B in a Previously Vaccinated Adult Male. Cureus. 2021;13(4):e14742. doi: https://doi.org/10.7759/cureus.14742

6. McNamara K, Hughes OB, Strowd LC. Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus. Clin Dermatol. 2020;38(6):641–647. doi: https://doi.org/10.1016/j.clindermatol.2020.06.013

7. Mathes EF, Gilliam AE. A four-year-old boy with fever, rash, and arthritis. Semin Cutan Med Surg. 2007;26(3):179–187. doi: https://doi.org/10.1016/j.sder.2007.09.001

8. Galvão Dos Santos de Araujo AC, Moura de Almeida L, Moura de Almeida AP, et al. Serum Sickness-Like Reaction: DrugInduced Cutaneous Disease in a Child. Dermatol Pract Concept. 2021;11(3):e2021029. doi: https://doi.org/10.5826/dpc.1103a29

9. Ali S, Corcea SL, Cristian RM, Bumbacea RS. A rapid desensitization protocol in a case of drotaverine-induced serum sickness-like reaction in a pregnant woman: A case report. Exp Ther Med. 2019;18(6):5105–5107. doi: https://doi.org/10.3892/etm.2019.8170

10. De Schryver S NE, Ben-Shoshan M. Severe serum sicknesslike reaction: Challenges in diagnosis and management. J C Exp Dermatol Res. 2015;6(3):1000279. doi: https://doi.org/10.4172/2155-9554.1000279

11. Milstien JB, Gross TP, Kuritsky JN. Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: An analysis after 1 year of marketing. Pediatrics. 1987;80(2):270–274.

12. Lindberg MR, Todd SP, Bunker DR, DeKlotz CMC. IxekizumabInduced Serum Sickness (Like Reaction): An Unusual Adverse Effect. J Clin Rheumatol. 2021;27(8S):S469–S470. doi: https://doi.org/10.1097/RHU.0000000000001222

13. Rixe N, Tavarez MM. Serum Sickness. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

14. Yerushalmi J, Zvulunov A, Halevy S. Serum sickness-like reactions. Cutis. 2002;69(5):395–397.

15. Yorulmaz A, Akın F, Sert A, et al. Demographic and clinical characteristics of patients with serum sickness-like reaction. Clin Rheumatol. 2018;37(5):1389–1394.

16. Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther. 2013;26(6):467–475. doi: https://doi.org/10.1111/dth.12103

17. Elzagallaai AA, Loubani E, Del Pozzo-Magaña BR, Rieder MJ. Pathogenesis of Beta-lactam-induced serum sickness-like reaction: The potential role of reactive drug metabolites. In: Authorea. April 07, 2020. doi: https://doi.org/10.22541/au.158629966.69248955

18. Shiari R, Eshgh FA, Rowshanzamir E, Derakhshanfar H. Clinical and laboratory profile of serum sickness-like reaction in children. Indian J Rheumatol. 2011;6(4):173–177. doi: https://doi.org/10.1016/S0973-3698(11)60203-3

19. Leung AKC, Leong KF, Lam JM. Acute Hemorrhagic Edema of Infancy: A Diagnostic Challenge for the General Pediatrician. Curr Pediatr Rev. 2020;16(4):285–293. doi: https://doi.org/10.2174/1573396316666200727145039

20. Medovic R, Medovic M, Igrutinovic Z, et al. Acute hemorrhagic edema of infancy — is it really a mild, benign disease? Turk J Pediatr. 2021;63(1):141–148. doi: https://doi.org/10.24953/turkjped.2021.01.017

21. Reamy BV, Servey JT, Williams PM. Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review. Am Fam Physician. 2020;102(4):229–233.

22. Ozen S, Marks SD, Brogan P, et al. European consensusbased recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019;58(9):1607–1616. doi: https://doi.org/10.1093/rheumatology/kez041

23. Gohari A, Matsell DG, Mammen C, Goldman RD. HenochSchönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease. Can Fam Physician. 2020;66(12): 895–897. doi: https://doi.org/10.46747/cfp.6612895

24. Song Y, Huang X, Yu G, et al. Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021;12:771619. doi: https://doi.org/10.3389/fimmu.2021.771619

25. Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Cutaneous Vasculitis: Review on Diagnosis and Clinicopathologic Correlations. Clin Rev Allergy Immunol. 2021;61(2):181–193. doi: https://doi.org/10.1007/s12016-020-08788-4

26. Mohta A, Mehta RD, Ghiya BC. Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis — A Double Whammy! Indian Pediatr. 2021;58(9): 894–895. doi: https://doi.org/10.1007/s13312-021-2317-0

27. Ivanchikov VV, Ambarchian ET, Kuzminova AD. COVID-19 Dermatological Manifestations in Children. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2022;19(2):105–114. (In Russ). doi: https://doi.org/10.15690/pf.v19i2.2398

28. Heras MO, Sancho MI, Munoz NP, Millet PU. Eosinophilic annular erythema in adults: report of two cases and review of literature. An Bras Dermatol. 2017;92(5 Suppl 1):65–68. doi: https://doi.org/10.1590/abd1806-4841.20176373

29. Lee HS, Yang JY, Kim YC. Eosinophilic annular erythema localized to the palms and the soles. Ann Dermatol. 2016;28(6):769–771. doi: https://doi.org/10.5021/ad.2016.28.6.769

30. Gordon S, Robinson S, Abudu M, et al. Eosinophilic annular erythema treated with dupilumab. Pediatr Dermatol. 2018;35(4): e255–e256. doi: https://doi.org/10.1111/pde.13533

31. Dacy N, Oney K, Fiala K, Parekh P. Eosinophilic annular erythema. Proc (Bayl Univ Med Cent). 2021;34(5):606–607. doi: https://doi.org/10.1080/08998280.2021.1922253

32. Torrelo A, Andina D, Santonja C, et al. Erythema multiformelike lesions in children and COVID-19. Pediatr Dermatol. 2020; 37(3):442–446. doi: https://doi.org/10.1111/pde.14246

33. Trayes KP, Love G, Studdiford JS. Erythema Multiforme: Recognition and Management. Am Fam Physician. 2019;100(2):82–88.